Goldman Sachs Starts Lifestance Health Group (LFST) at Neutral

Goldman Sachs analyst Jamie Perse initiates coverage on Lifestance Health Group (NASDAQ: LFST) with a Neutral rating and a price target of $25.00.

The analyst comments "LifeStance is a leading provider of outpatient mental health services focused on reducing barriers to treatment. LFST competes in a large ($115B in 2020) and growing TAM estimated to reach $215B by 2025, a low-teens CAGR. A unique strategy around clinician employment, primary care partnerships, in-network payor coverage, and hybrid care delivery creates a differentiated asset that we find highly attractive in the long run. With strong stock performance post IPO, valuation is the primary factor that keeps us at Neutral."

For an analyst ratings summary and ratings history on Lifestance Health Group click here. For more ratings news on Lifestance Health Group click here.

Shares of Lifestance Health Group closed at $27.63 yesterday.

You May Also Be Interested In

• On Holding AG (ONON)PT Lowered to $42 at Goldman Sachs
• Berenberg Starts Raspberry PI Holdings PLC (RPI:LN) at Hold
• Kepler Cheuvreux Upgrades Zehnder Group AG (ZEHN:SW) to Buy